Transmedics Group Inc
NASDAQ:TMDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Transmedics Group Inc
NASDAQ:TMDX
|
US |
|
B
|
Bion Environmental Technologies Inc
OTC:BNET
|
US |
|
A
|
Arcelormittal South Africa Ltd
XMUN:ISC1
|
ZA |
|
A
|
Alzchem Group AG
DUS:ACT
|
DE |
|
F
|
Focus Minerals Ltd
F:FZA
|
AU |
|
V
|
Vicinity Centres
F:C98
|
AU |
|
Alzchem Group AG
F:ACT
|
DE |
Intrinsic Value
Is TMDX undervalued or overvalued?
See the intrinsic value estimate for Transmedics Group Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
TMDX looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with TMDX’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Transmedics Group Does
TransMedics Group makes equipment and services for organ transplantation. Its main product is the Organ Care System, a portable platform that keeps donated organs functioning outside the body during transport, instead of storing them on ice. The company also provides the logistics and clinical support needed to move organs from donor to transplant center.
- Headquarters
- United States of America US
- Employees
- 898
- IPO date
- May 2, 2019
Revenue & Expenses Breakdown
Transmedics Group Inc
Earnings Waterfall
Transmedics Group Inc
The intrinsic value for Transmedics Group Inc (TMDX) under the Base Case is hidden USD.
Compared with the current market price of 71.635 USD, the stock appears hidden.